Anaphylaxis in an emergency setting - Elicitors, therapy and incidence of severe allergic reactions

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 11, 2012, Pages 1451-1456

  Beyer, K ^a   Eckermann, O ^a   Hompes, S ^a   Grabenhenrich, L ^a   Worm, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

adrenaline; anaphylaxis; emergency; treatment protocol

Indexed keywords

ADRENALIN; ALLERGEN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CEPHALOSPORIN; CORTICOSTEROID; DIPYRONE; GLUCOCORTICOID; IBUPROFEN; INSECT VENOM; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLONE DERIVATIVE;

ALMOND; ANAPHYLAXIS; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; EMERGENCY CARE; EMERGENCY PHYSICIAN; FATALITY; FISH; FLUID THERAPY; FOOD; FRUIT; GERMANY; HOUSE FLY; HUMAN; IMMUNOTHERAPY; INCIDENCE; MAJOR CLINICAL STUDY; NUT; PRIORITY JOURNAL; VEGETABLE; VESPA; WASP;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; CHILD; EMERGENCIES; FEMALE; FOOD HYPERSENSITIVITY; GERMANY; HUMANS; HYPOTENSION; INCIDENCE; MALE; MIDDLE AGED; SKIN DISEASES;

EID: 84867515601     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12012     Document Type: Article

References (36)

1. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836.
2. Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 2011; 127: 587-593.
3. Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115: 584-591.
4. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397.
5. Ring J,. Akuttherapie anaphylaktischer Reaktionen. Allergo J 2007; 16: 420-434.
6. Clark S, Gaeta TJ, Kamarthi GS, Camargo CA,. ICD-9-CM coding of emergency department visits for food and insect sting allergy. Ann Epidemiol 2006; 16: 696-700.
7. Clark S, Long AA, Gaeta TJ, Camargo CA Jr,. Multicenter study of emergency department visits for insect sting allergies. J Allergy Clin Immunol 2005; 116: 643-649.
8. Smit DV, Cameron PA, Rainer TH,. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med 2005; 28: 381-388.
9. Bellou A, Manel J, Samman-Kaakaji H, de Korwin JD, Moneret-Vautrin DA, Bollaert PE, et al. Spectrum of acute allergic diseases in an emergency department: an evaluation of one years' experience. Emerg Med (Fremantle) 2003; 15: 341-347.
10. Brown AF, McKinnon D, Chu K,. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108: 861-866.
11. Campbell RL, Luke A, Weaver AL, St Sauver JL, Bergstralh EJ, Li JT, et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol 2008; 101: 631-636.
12. Clark S, Bock SA, Gaeta TJ, Brenner BE, Cydulka RK, Camargo CA,. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol 2004; 113: 347-352.
13. Helbling A, Hurni T, Mueller UR, Pichler WJ,. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004; 34: 285-290.
14. Pastorello EA, Rivolta F, Bianchi M, Mauro M, Pravettoni V,. Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J Chromatogr B Biomed Sci Appl 2001; 756: 11-17.
15. Sheikh A, Alves B,. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 2001; 31: 1571-1576.
16. Simons FE, Peterson S, Black CD,. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 2002; 110: 647-651.
17. Stewart AG, Ewan PW,. The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department. QJM 1996; 89: 859-864.
18. Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD,. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999; 104 (2 Pt 1): 452-456.
19. Lieberman P, Camargo CA Jr, Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006; 97: 596-602.
20. Mäkinen-Kiljunen S, Haahtela T,. Eight years of severe allergic reactions in Finland. WAO Journal November 2008; 2008: 184-189.
21. Sheikh A, Hippisley-Cox J, Newton J, Fenty J,. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008; 101: 139-143.
22. Anaphylaxis-registry. Statistics. [cited August 14, 2011]; Available from: http://www.anaphylaxie.net/.
23. Grüber C,. Zehn Jahre Multizentrische Allergiestudie MAS-90. ImpfDialog 2002; 4: 183-187.
24. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007; 62: 857-871.
25. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008; 122: 1161-1165.
26. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G,. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60: 443-451.
27. Worm M, Edenharter G, Rueff F, Scherer K, Pfohler C, Mahler V, et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67: 691-698.
28. Kulthanan K, Wongkamchai S, Triwongwaranat D,. Mosquito allergy: clinical features and natural course. J Dermatol 2010; 37: 1025-1031.
29. Bilo MB,. Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment. Allergy 2011; 66 (Suppl. 95): 35-37.
30. Centers for Disease Control and Prevention (CDC). Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001-2009. MMWR Morb Mortal Wkly Rep 2011; 60: 547-552.
31. Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LA,. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010; 125: 1098-1104 e1091.
32. Clark S, Camargo CA Jr,. Emergency treatment and prevention of insect-sting anaphylaxis. Curr Opin Allergy Clin Immunol 2006; 6: 279-283.
33. Simons KJ, Simons FE,. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol 2010; 10: 354-361.
34. Pumphrey RS,. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp 2004; 257: 116-128; discussion 128-132, 157-160, 276-185.
35. Simons FE,. Anaphylaxis pathogenesis and treatment. Allergy 2011; 66 (Suppl. 95): 31-34.
36. Grabenhenrich L, Hompes S, Gough H, Rueff F, Scherer K, Pfohler C, et al. Implementation of anaphylaxis management guidelines: a register-based study. PLoS ONE 2012; 7: e35778.